HOME >> BIOLOGY >> NEWS
Research funded to test new breast cancer medicine

BLACKSBURG, Va., July 9, 2001 Virginia Tech researchers in human nutrition and dairy science are beginning animal trials to test a new compound against breast cancer, thanks to a grant from Virginias Commonwealth Health Research Board (CHRB).

Barbara Davis, an assistant professor in human nutrition, foods, and exercise, is the lead investigator in a research project that will test the novel Schiff base-forming drug, which is known to strengthen the immune system -- an important mechanism for fighting cancer. Research from Davis lab has shown that this drug can kill breast cancer cells growing outside the body, without the help of the immune system.

Davis has already reported that a molecule of similar structure, vitamin B6, is effective at killing breast cancer cells, but the drug she is now testing can safely be used in humans at higher doses than B6 and therefore may represent a better breast cancer treatment option.

In collaboration with Mike Akers, the Alphin Professor of Dairy Science at Virginia Tech, and Prakash Nagarkatti, a researcher at the Medical College of Virginia, Davis will treat breast cancer in two types of mice, those with normal and those with weakened immune systems.

These experiments will help determine the involvement of the immune system in the cancer-killing ability of this drug. More importantly, they will show whether it is effective in treating breast cancer in the body.

The project is especially significant to Virginians, because mortality from breast cancer in Virginia is higher than the national average, although the incidence of breast cancer is below the national average, said Davis.


'"/>

Contact: Jean Elliott
elliottj@vt.edu
540 -231-5915
Virginia Tech
9-Jul-2001


Page: 1

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... ... April 20, 2017 , ... Open Therapeutics and ... (IP) sharing and commercialization model. , The Center for Advancing Innovation helps institutions ... this effort is bringing the IP to the attention of the entrepreneurial community ...
(Date:4/19/2017)... ... 18, 2017 , ... The Vibrating Orifice Aerosol Generator (VOAG) ... monodisperse droplets of known diameters for research applications such as for calibrating droplet ... drying monodisperse droplets. , The VOAG requires forcing liquid out of an ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of ... Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis ... clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of ...
(Date:4/19/2017)... , April 19, 2017 A new report published ... Industry Forecast, 2014-2022 ," the global market was valued at $6,769 million in ... of 9.6% from 2016 to 2022. ... Allied Market Research ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology Technology:
Cached News: